← Previous Post: | Next Post:


The workshop follows recent controversies in Australia over commercially-funded clinical practice guidelines for venous thromboembolism prevention, and a sponsorship deal between Sanofi-Aventis and the Baker IDI Heart and Diabetes Institute which was in breach of the Medicines Australia code of conduct.

Australia takes up conflict of interest.

Trackback URL for this post:

Comment on this Entry

Latest UD posts at IHE